Clumps or plaques of the protein beta-amyloid in the brain are a hallmark of a type of dementia called Alzheimer’s disease. When beta-amyloid plaques form, they disrupt communication between nerve ...
The new treatment approach targets restoring normal blood vessel function instead of focusing on neurons or other brain cells, which has been the common strategy until now. A team of scientists co-led ...
A quiet shift in dementia science is gathering pace, with lab results hinting at a fresh route to protect fading memories. A team working across China and ...
A new study has identified a mutation in the TREM2 gene that disrupts the brain’s ability to clear toxic amyloid plaques, ...
Spanish and Chinese scientists say they have used nanoparticles to enable the brains of mice to clear out plaque linked to ...
POTOMAC, Md.--(BUSINESS WIRE)--IGC Pharma, Inc. (NYSE American: IGC) ("IGC" or the "Company") today announced encouraging preclinical results in an Alzheimer’s mouse model demonstrating the potential ...
Alzheimer's disease is notorious for scrambling patients' daily rhythms. Restless nights with little sleep and increased ...
In the search for answers about Alzheimer’s disease, researchers are taking a close look at the immune system of the brain. A new study uncovers how a key immune cell, called a microglia, might be the ...
A deficiency of the metal lithium in the body could be a key factor contributing to the development of dementia in Alzherimer’s patients, a groundbreaking new study reveals. The decade-long research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback